387 related articles for article (PubMed ID: 22427237)
1. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.
Syn WK; Agboola KM; Swiderska M; Michelotti GA; Liaskou E; Pang H; Xie G; Philips G; Chan IS; Karaca GF; Pereira Tde A; Chen Y; Mi Z; Kuo PC; Choi SS; Guy CD; Abdelmalek MF; Diehl AM
Gut; 2012 Sep; 61(9):1323-9. PubMed ID: 22427237
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.
Syn WK; Choi SS; Liaskou E; Karaca GF; Agboola KM; Oo YH; Mi Z; Pereira TA; Zdanowicz M; Malladi P; Chen Y; Moylan C; Jung Y; Bhattacharya SD; Teaberry V; Omenetti A; Abdelmalek MF; Guy CD; Adams DH; Kuo PC; Michelotti GA; Whitington PF; Diehl AM
Hepatology; 2011 Jan; 53(1):106-15. PubMed ID: 20967826
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.
Syn WK; Oo YH; Pereira TA; Karaca GF; Jung Y; Omenetti A; Witek RP; Choi SS; Guy CD; Fearing CM; Teaberry V; Pereira FE; Adams DH; Diehl AM
Hepatology; 2010 Jun; 51(6):1998-2007. PubMed ID: 20512988
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
[TBL] [Abstract][Full Text] [Related]
6. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
[TBL] [Abstract][Full Text] [Related]
8. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin: Versatile modulator of liver diseases.
Nagoshi S
Hepatol Res; 2014 Jan; 44(1):22-30. PubMed ID: 23701387
[TBL] [Abstract][Full Text] [Related]
10. Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Heinrichs D; Brandt EF; Fischer P; Köhncke J; Wirtz TH; Guldiken N; Djudjaj S; Boor P; Kroy D; Weiskirchen R; Bucala R; Wasmuth HE; Strnad P; Trautwein C; Bernhagen J; Berres ML
Cells; 2021 Jan; 10(2):. PubMed ID: 33525493
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
[TBL] [Abstract][Full Text] [Related]
12. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
[TBL] [Abstract][Full Text] [Related]
13. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
Arriazu E; Ge X; Leung TM; Magdaleno F; Lopategi A; Lu Y; Kitamura N; Urtasun R; Theise N; Antoine DJ; Nieto N
Gut; 2017 Jun; 66(6):1123-1137. PubMed ID: 26818617
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.
Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS
World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703
[TBL] [Abstract][Full Text] [Related]
15. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
Urtasun R; Lopategi A; George J; Leung TM; Lu Y; Wang X; Ge X; Fiel MI; Nieto N
Hepatology; 2012 Feb; 55(2):594-608. PubMed ID: 21953216
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
18. Repair-associated inflammation in nonalcoholic fatty liver disease.
Syn WK
Clin Med (Lond); 2013 Dec; 13 Suppl 6():s15-9. PubMed ID: 24298175
[TBL] [Abstract][Full Text] [Related]
19. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.
Sutti S; Jindal A; Locatelli I; Vacchiano M; Gigliotti L; Bozzola C; Albano E
Hepatology; 2014 Mar; 59(3):886-97. PubMed ID: 24115128
[TBL] [Abstract][Full Text] [Related]
20. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis.
Cui G; Chen J; Wu Z; Huang H; Wang L; Liang Y; Zeng P; Yang J; Uede T; Diao H
J Cell Physiol; 2019 Jun; 234(6):8988-8997. PubMed ID: 30350863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]